SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) disclosed today that it has shipped Hemopurifier® treatment cartridges to support a clinical study to be conducted at the Fortis Hospital (www.fortishealthcare.com) in Delhi, India. The study, which will evaluate the safety of the Hemopurifier® in ten patients, is expected to commence in the coming month.
